Mind Medicine receives Nasdaq listing approval
2021-04-23 07:57 ET – News Release Mr. J.R. Rahn reports MINDMED TO COMMENCE TRADING ON NASDAQ Mind Medicine (MindMed) Inc.’s subordinate voting shares have been approved for listing on the Nasdaq Capital Market. Trading is expected to begin on Tuesday, April 27, 2021, under the symbol “MNMD” on the Nasdaq. MindMed will retain its listing on the Neo Exchange Inc. under the symbol “MMED” and the Company’s subordinate voting shares will continue to...
read more